Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
The complete blood count device market has been witnessing steady expansion recently, driven by advancements in diagnostic technologies and a growing need for efficient healthcare solutions. With rising investments and innovations, this sector is set to experience notable growth over the coming years. Let’s explore the market size, key drivers, segmentation, emerging trends, major players, and regional outlook to understand its future trajectory.
Overview of Market Size and Growth Prospects for Complete Blood Count Devices
The market for complete blood count devices has seen substantial growth, with its value rising from $4.33 billion in 2025 to an estimated $4.58 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.0%. This expansion during the historical period has been driven by increasing clinical diagnostic testing volumes, enhanced automation in hospital laboratories, a growing burden of chronic illnesses, widespread use of standardized blood testing protocols, and a higher demand for routine health check-ups. Looking ahead, the market is projected to reach $5.76 billion by 2030, growing at a CAGR of 5.9%. Factors contributing to this forecast include greater adoption of decentralized diagnostic approaches, increased investments in smart lab infrastructure, demand for rapid test results, expanded preventive healthcare screening, and ongoing advances in hematology technologies. Key trends anticipated during this period encompass the rising use of automated hematology analyzers, growing popularity of point-of-care complete blood count devices, integration of AI-powered diagnostics, expansion of high-throughput laboratory systems, and an intensifying focus on diagnostic accuracy and speed.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24195&type=smp
Key Factors Propelling Growth in the Complete Blood Count Device Market
The increasing incidence of blood disorders stands as a significant driver behind the growth of the complete blood count device market. Blood disorders impact the production, function, or structure of blood cells, leading to compromised blood performance. The rising frequency of lifestyle-related diseases—caused by poor nutrition, inactivity, and stress—has contributed to conditions such as anemia and clotting abnormalities. Complete blood count devices play an essential role in diagnosing these blood disorders by analyzing critical blood components and detecting abnormalities, enabling healthcare providers to identify clotting issues and administer timely, accurate treatment. For example, in May 2024, the Canadian Cancer Society reported that 4,100 Canadians were diagnosed with multiple myeloma, a form of blood cancer, while 1,750 succumbed to the disease, highlighting the growing need for reliable blood analysis tools. This increase in blood disorder prevalence continues to fuel demand for complete blood count devices.
Additional Market Drivers Supporting Expansion
Another catalyst for market growth is the ongoing enhancement of laboratory workflows through automation and the incorporation of smart technology. Hospitals and diagnostic centers are upgrading their facilities to accommodate automated, high-throughput hematology analyzers that deliver faster and more precise results. Moreover, rising awareness about preventive healthcare and routine screening programs is encouraging more frequent blood testing, further expanding the market. The shift towards point-of-care testing is also significant, as healthcare providers seek portable, user-friendly devices that enable quicker diagnostics at or near the patient, reducing reliance on centralized labs.
Access The Complete Complete Blood Count Device Market Report:
https://www.thebusinessresearchcompany.com/report/complete-blood-count-device-global-market-report
Segmentation Breakdown of the Complete Blood Count Device Market
This market is segmented across several dimensions to provide a detailed understanding of its structure:
1) Device Types: Automated Blood Count Analyzers, Manual Blood Count Analyzers, Point-Of-Care Testing Devices, and Hematology Analyzers.
2) Test Types: Covering White Blood Cell Count (WBC/Leukocyte), WBC Differential Count, Red Blood Cell Count (RBC/Erythrocyte), Hematocrit (Hct), Hemoglobin (Hbg), Platelet Count, Mean Platelet Volume (MPV), Mean Corpuscular Hemoglobin (MCH), and others.
3) Technologies: Including Impedance Technology, Laser-Based Technology, Flow Cytometry, and Microscopy.
4) Distribution Channels: Such as Direct Sales, Online Sales, Third-Party Distributors, and Laboratory Equipment Suppliers.
5) End-Users: Hospitals, Diagnostic Laboratories, Research Institutes, and other users.
Further subcategories exist within these segments. For example, Automated Blood Count Analyzers include 3-Part, 5-Part, and 6-Part and above Differential Analyzers, Integrated Hematology Systems, and High-Throughput Lab Analyzers. Manual Analyzers cover Hemocytometers, Microscopes for Manual Differentials, Manual Cell Counters, and Staining Kits. Point-of-Care Devices involve Portable Hematology Analyzers, Handheld CBC Devices, Fingerstick Blood Test Devices, and Rapid Diagnostic CBC Kits. Hematology Analyzers are divided into Low-, Mid-, and High-Volume analyzers, including Veterinary and Reagent-Free models.
Emerging Trends Shaping Long-Term Demand in the Complete Blood Count Device Market
Leading companies in this market are focusing on launching advanced, compact hematology analyzers that offer accurate, rapid, and cost-effective solutions suitable for point-of-care testing. These portable devices require minimal sample volumes and provide quick complete blood count results, enhancing diagnostic efficiency and accessibility. Such innovations improve ease of use and maintenance, making them attractive options in various healthcare settings. For instance, in June 2024, HORIBA introduced the Yumizen H550E and H500E analyzers, which integrate erythrocyte sedimentation rate (ESR) testing with CBC and 5-part differential analyses. These devices employ HORIBA’s patented CoRA (correlated rouleaux analysis) technology to deliver comprehensive blood examination results from whole blood samples within 60 seconds.
Additional Trends Driving Market Innovation
Apart from miniaturization and speed, the market is witnessing growing integration of artificial intelligence and machine learning within diagnostic tools. AI-based diagnostics enhance the precision and interpretation of hematology results, while high-throughput systems streamline laboratory workflows to handle increasing test volumes efficiently. These technological improvements help laboratories meet rising demand for both routine and specialized blood analysis.
Competitive Landscape of the Complete Blood Count Device Market
Key players in the complete blood count device industry include major global companies such as Abbott Laboratories, Siemens Healthineers, Mindray Medical International Limited, Beckman Coulter Inc., Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Agappe Diagnostics Ltd., Trivitron Healthcare Pvt. Ltd., HemoCue AB, EKF Diagnostics Holdings plc, Erba Mannheim, Boule Diagnostics AB, Biosystems S.A., Diatron MI Zrt., Labtron Equipment Ltd., Microlab Instruments Co. Pvt. Ltd., URIT Medical Electronic Co. Ltd., Roche Diagnostics, Ortho Clinical Diagnostics, BioSystems Diagnostics Pvt. Ltd., Drew Scientific (an EKF subsidiary), Analyticon Biotechnologies GmbH, and Rayto Life and Analytical Sciences Co. Ltd. These companies continue to invest in research and development to bring innovative, reliable, and user-friendly devices to the market.
Regional Perspectives and Growth Opportunities in the Complete Blood Count Device Industry
In 2025, North America held the largest market share for complete blood count devices, supported by advanced healthcare infrastructure and strong adoption of diagnostic technologies. Meanwhile, the Asia-Pacific region is expected to experience the fastest growth throughout the forecast period. This growth is driven by rising healthcare expenditures, increasing prevalence of chronic and lifestyle diseases, expanding healthcare access, and a growing middle class demanding better diagnostic services. The market report covers critical regions including Asia-Pacific, South East Asia, Western and Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive global perspective on market trends and regional opportunities.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
